Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juergen Drewe

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Expert Opinion on Drug Discovery|March 31, 2012
Decision tree models for data mining in hit discoveryFelix Hammann, Juergen Drewe
Expert Opinion on Drug Metabolism & Toxicology|March 5, 2014
Data mining for potential adverse drug-drug interactionsFelix Hammann, Juergen Drewe
Cancer Chemotherapy and Pharmacology|September 2, 2005
Thalidomide does not interact with P-glycoproteinChristian Zimmermann, Heike Gutmann, Juergen Drewe
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 3, 2006
Primary porcine proximal tubular cells as a model for transepithelial drug transport in human kidneyPhilipp Schlatter, Heike Gutmann, Juergen Drewe
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 30, 2013
The effect of a Cimicifuga racemosa extracts Ze 450 in the treatment of climacteric complaints--an observational studyJuergen Drewe, Christian Zimmermann, Catherine Zahner
Planta Medica|December 15, 2007
Piper cubeba targets multiple aspects of the androgen-signalling pathway. A potential phytotherapy against prostate cancer growth?Jianying Yam, Matthias Kreuter, Juergen Drewe
Molecular Pharmaceutics|August 13, 2010
A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinibAngelika Graber-Maier, Heike Gutmann, Juergen Drewe
Expert Opinion on Drug Metabolism & Toxicology|October 20, 2010
Pharmacokinetic evaluation of idebenoneClaudia Becker, Katharine Bray-French, Juergen Drewe
Springerplus|February 26, 2015
A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patientsJuergen Drewe, Kathleen A Bucher, Catherine Zahner
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell linesDebora Porath, Christoph Riegger, Juergen Drewe, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Expert Opinion on Drug Discovery|March 31, 2012
Decision tree models for data mining in hit discoveryFelix Hammann, Juergen Drewe
Expert Opinion on Drug Metabolism & Toxicology|March 5, 2014
Data mining for potential adverse drug-drug interactionsFelix Hammann, Juergen Drewe
Cancer Chemotherapy and Pharmacology|September 2, 2005
Thalidomide does not interact with P-glycoproteinChristian Zimmermann, Heike Gutmann, Juergen Drewe
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 3, 2006
Primary porcine proximal tubular cells as a model for transepithelial drug transport in human kidneyPhilipp Schlatter, Heike Gutmann, Juergen Drewe
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 30, 2013
The effect of a Cimicifuga racemosa extracts Ze 450 in the treatment of climacteric complaints--an observational studyJuergen Drewe, Christian Zimmermann, Catherine Zahner
Planta Medica|December 15, 2007
Piper cubeba targets multiple aspects of the androgen-signalling pathway. A potential phytotherapy against prostate cancer growth?Jianying Yam, Matthias Kreuter, Juergen Drewe
Molecular Pharmaceutics|August 13, 2010
A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinibAngelika Graber-Maier, Heike Gutmann, Juergen Drewe
Expert Opinion on Drug Metabolism & Toxicology|October 20, 2010
Pharmacokinetic evaluation of idebenoneClaudia Becker, Katharine Bray-French, Juergen Drewe
Springerplus|February 26, 2015
A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patientsJuergen Drewe, Kathleen A Bucher, Catherine Zahner
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell linesDebora Porath, Christoph Riegger, Juergen Drewe, et al.
Pageof 6